Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina Martelli

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|March 6, 2021
The Multifaceted Role of CMA in Glioma: Enemy or Ally?Alessia Lo Dico, Cristina Martelli, Cecilia Diceglie, et al.
Trends in Biotechnology|July 28, 2006
Molecular imaging of cell-mediated cancer immunotherapyGiovanni Lucignani, Luisa Ottobrini, Cristina Martelli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 21, 2010
In vivo imaging of immune cell trafficking in cancerLuisa Ottobrini, Cristina Martelli, Daria Lucia Trabattoni, et al.
Frontiers in Oncology|July 18, 2018
Hypoxia-Inducible Factor-1α Activity as a Switch for Glioblastoma Responsiveness to TemozolomideAlessia Lo Dico, Cristina Martelli, Cecilia Diceglie, et al.
Oncotarget|May 5, 2016
Optical imaging probes in oncologyCristina Martelli, Alessia Lo Dico, Cecilia Diceglie, et al.
Cells|October 27, 2019
Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in GlioblastomaAlessia Lo Dico, Daniela Salvatore, Cristina Martelli, et al.
Scientific Reports|March 23, 2021
Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidatesGloria Bertoli, Claudia Cava, Fabio Corsi, et al.
Breast Cancer Research and Treatment|December 22, 2016
MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migrationGloria Bertoli, Claudia Cava, Cecilia Diceglie, et al.
Molecular Imaging|June 6, 2015
In vivo imaging study of angiogenesis in a channelized porous scaffoldMargherita Tamplenizza, Alessandro Tocchio, Irini Gerges, et al.
Theranostics|January 7, 2020
Theranostic application of <i>miR-429</i> in HER2+ breast cancerClaudia Cava, Chiara Novello, Cristina Martelli, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|March 6, 2021
The Multifaceted Role of CMA in Glioma: Enemy or Ally?Alessia Lo Dico, Cristina Martelli, Cecilia Diceglie, et al.
Trends in Biotechnology|July 28, 2006
Molecular imaging of cell-mediated cancer immunotherapyGiovanni Lucignani, Luisa Ottobrini, Cristina Martelli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 21, 2010
In vivo imaging of immune cell trafficking in cancerLuisa Ottobrini, Cristina Martelli, Daria Lucia Trabattoni, et al.
Frontiers in Oncology|July 18, 2018
Hypoxia-Inducible Factor-1α Activity as a Switch for Glioblastoma Responsiveness to TemozolomideAlessia Lo Dico, Cristina Martelli, Cecilia Diceglie, et al.
Oncotarget|May 5, 2016
Optical imaging probes in oncologyCristina Martelli, Alessia Lo Dico, Cecilia Diceglie, et al.
Cells|October 27, 2019
Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in GlioblastomaAlessia Lo Dico, Daniela Salvatore, Cristina Martelli, et al.
Scientific Reports|March 23, 2021
Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidatesGloria Bertoli, Claudia Cava, Fabio Corsi, et al.
Breast Cancer Research and Treatment|December 22, 2016
MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migrationGloria Bertoli, Claudia Cava, Cecilia Diceglie, et al.
Molecular Imaging|June 6, 2015
In vivo imaging study of angiogenesis in a channelized porous scaffoldMargherita Tamplenizza, Alessandro Tocchio, Irini Gerges, et al.
Theranostics|January 7, 2020
Theranostic application of <i>miR-429</i> in HER2+ breast cancerClaudia Cava, Chiara Novello, Cristina Martelli, et al.
Pageof 4